{
    "Symbol": "TECH",
    "AssetType": "Common Stock",
    "Name": "Bio-Techne Corp",
    "Description": "Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.",
    "CIK": "842023",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "614 MCKINLEY PL N E, MINNEAPOLIS, MN, US",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "11430747000",
    "EBITDA": "351941000",
    "PERatio": "45.14",
    "PEGRatio": "1.148",
    "BookValue": "11.63",
    "DividendPerShare": "0.32",
    "DividendYield": "0.0044",
    "EPS": "1.61",
    "RevenuePerShareTTM": "7.14",
    "ProfitMargin": "0.234",
    "OperatingMarginTTM": "0.257",
    "ReturnOnAssetsTTM": "0.0771",
    "ReturnOnEquityTTM": "0.148",
    "RevenueTTM": "1119840000",
    "GrossProfitTTM": "758092000",
    "DilutedEPSTTM": "1.61",
    "QuarterlyEarningsGrowthYOY": "-0.367",
    "QuarterlyRevenueGrowthYOY": "0.009",
    "AnalystTargetPrice": "101.12",
    "TrailingPE": "45.14",
    "ForwardPE": "42.19",
    "PriceToSalesRatioTTM": "11.83",
    "PriceToBookRatio": "7.78",
    "EVToRevenue": "12.32",
    "EVToEBITDA": "30.43",
    "Beta": "1.212",
    "52WeekHigh": "112.94",
    "52WeekLow": "67.6",
    "50DayMovingAverage": "80.41",
    "200DayMovingAverage": "83.23",
    "SharesOutstanding": "157275000",
    "DividendDate": "2023-02-27",
    "ExDividendDate": "2023-02-10"
}